Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inclusion body myositis.

A Oldfors1, C Lindberg

  • 1Department of Pathology, Göteborg Neuromuscular Center, Sahlgrenska University Hospital, Sweden. anders.oldfors@ss.gu.se

Current Opinion in Neurology
|December 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel homozygous pathogenic missense variant in COX6B1: Further delineation of the phenotype.

American journal of medical genetics. Part A·2024
Same author

New mutations identified in a case of Glycogenin-1 deficiency.

Molecular genetics and metabolism reports·2024
Same author

Sexually dimorphic differences in angiogenesis markers predict brain aging trajectories.

bioRxiv : the preprint server for biology·2023
Same author

Body composition in patients with primary neuromuscular disease assessed by dual energy X-ray absorptiometry (DXA) and three different bioimpedance devices.

Clinical nutrition ESPEN·2019
Same author

Polyglucosan myopathy and functional characterization of a novel GYG1 mutation.

Acta neurologica Scandinavica·2017
Same author

Distinctive cerebral neuropathology in an adult case of sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) syndrome.

Neuropathology and applied neurobiology·2017
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Sporadic inclusion body myositis is a disabling muscle disease affecting the elderly. Recent research improves understanding of its causes, leading to better insights into muscle degeneration and weakness.

Area of Science:

  • Neurology
  • Muscle Diseases
  • Pathology

Background:

  • Sporadic inclusion body myositis (IBM) is a severe, disabling neuromuscular disorder primarily affecting older adults.
  • Characterized by progressive muscle weakness, particularly in proximal and distal muscles, leading to significant disability.
  • The disease's resistance to immunosuppressive therapies highlights the need for deeper etiological understanding.

Purpose of the Study:

  • To synthesize recent research advancements in understanding the pathogenesis of sporadic inclusion body myositis.
  • To elucidate the molecular and cellular mechanisms underlying muscle degeneration in IBM.
  • To identify key pathological features contributing to disease progression and weakness.

Main Methods:

  • Review of recent scientific literature focusing on IBM.

Related Experiment Videos

  • Analysis of studies investigating protein aggregation, inflammation, and mitochondrial dysfunction in IBM muscle biopsies.
  • Examination of research on the genetic and environmental factors potentially involved in IBM pathogenesis.

    • Main Results:

    • Recent research has enhanced the understanding of pathogenic events in IBM.
    • Key findings include insights into the pathological accumulation of proteins within vacuolated muscle fibers.
    • Mitochondrial changes and inflammatory reactions are increasingly recognized as significant contributors to muscle degeneration.

    Conclusions:

    • Continued research into IBM pathogenesis is crucial for developing effective treatments.
    • Understanding the complex interplay of proteinopathies, inflammation, and mitochondrial dysfunction is key to addressing muscle degeneration.
    • Further investigation holds promise for improving therapeutic strategies for this debilitating muscle disease.